Table 4.
Experiment 1 (NBQX) statistical analyses results
| Table 4A. NBQX | |
|---|---|
| 2 sex X 2 age X 6 dose Repeated Measure ANOVA | |
| Age | F(1,193)=16.679; p=0.000 |
| Sex | F(1.193)=23.517; p=0.000 |
| Dose | F(5,193)=0.529; p=0.754 |
| Age*Sex | F(1,193)=5.202; p=0.024 |
| Age*Dose | F(5,193)=1.438; p=0.212 |
| Sex*Dose | F(5,193)=0.928; p=0.464 |
| Age*Sex*Dose | F(5,193)=1.395; p=0.228 |
| Day | F(1,193)=174.933; p=0.000 |
| Day*Age | F(1,193)=19.716; p=0.000 |
| Day*Sex | F(1,193)=0.854; p=0.356 |
| Day*Dose | F(5,193)=2.187; p=0.057 |
| Day*Age*Sex | F(1,193)=0.416; p=0.520 |
| Day*Age*Dose | F(5,193)=1.003; p=0.417 |
| Day*Sex*Dose | F(5,193)=0.784; p=0.562 |
| Day*Age*Sex*Dose | F(5,193)=2.130; p=0.064 |
| Table 4B. NBQX | |
| 2 sex X 2 age X 6 dose ANOVA of %Control Intake | |
| Age | F(1,193)=2.518; p=0.114 |
| Sex | F(1,193)=0.338; p=0.561 |
| Dose | F(5,193)=1.286; p=0.271 |
| Age*Sex | F(1,193)=21.136; p=0.000 |
| Age*Dose | F(5,193)=1.979; p=0.083 |
| Sex*Dose | F(5,193)=1.343; p=0.248 |
| Age*Sex*Dose | F(5,193)=1.844; p=0.105 |
| Table 4C. NBQX | |
| Repeated Measure ANOVAs within each age/sex group | |
| Adolescent Females | Dose: F(5,48)=2.243; p=0.065 |
| Day: F(1,48)=16.729; p=0.000 | |
| Day*Dose: F(5,48)=3.204; p=0.014 | |
| Adolescent Males | Dose: F(5,50)=0.821; p=0.541 |
| Day: F(1,50)=26.899; p=0.000 | |
| Day*Dose: F(5,50)=0.689; p=0.634 | |
| Adult Females | Dose: F(5,46)=1.249; p=0.302 |
| Day: F(1,46)=71.366; p=0.000 | |
| Day*Dose: F(5,46)=1.196; p=0.326 | |
| Adult Males | Dose: F(5,49)=0.828; p=0.536 |
| Day: F(1,49)=69.498; p=0.000 | |
| Day*Dose: F(5,49)=1.447; p=0.224 | |
| Table 4D. NBQX | |
| %Control one-way ANOVA within each age/sex group | |
| Adolescent Females | F(5,48)=2.748; p=0.029 |
| Adolescent Males | F(5.50)=0.633; p=0.675 |
| Adult Females | F(5,46)=1.373; p=0.252 |
| Adult Males | F(5,49)=0.880; p=0.502 |